Share Twitter LinkedIn Facebook Email Sen Zhuang, MD, PhD, VP, Oncology Clinical Research, Janssen, Discusses LCAR-838M Study In Relapsed/Refractory MM At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read